These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37019180)

  • 1. Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent nonalcoholic fatty liver disease in Hispanic children.
    Welsh JA; Pyo E; Huneault H; Gonzalez Ramirez L; Alazraki A; Alli R; Dunbar SB; Khanna G; Knight-Scott J; Pimentel A; Reed B; Rodney-Somersall C; Santoro N; Umpierrez G; Vos MB
    Contemp Clin Trials; 2023 Jun; 129():107170. PubMed ID: 37019180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
    Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
    JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
    Schmidt KA; Jones RB; Rios C; Corona Y; Berger PK; Plows JF; Alderete TL; Fogel J; Hampson H; Hartiala JA; Cai Z; Allayee H; Nayak KS; Sinatra FR; Harlan G; Pickering TA; Salvy SJ; Mack WJ; Kohli R; Goran MI
    J Nutr; 2022 Jul; 152(7):1655-1665. PubMed ID: 35218194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
    Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
    Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study).
    Zhang PP; Wang YX; Shen FJ; Xing YF; Gu JY; Li XY; Jin H; Jin SF; Xu M; Wang HJ; Wang H; Li L
    Trials; 2024 Mar; 25(1):196. PubMed ID: 38504343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Lee HA; Moon H; Kim Y; Lee HA; Kim HY
    Trials; 2023 Aug; 24(1):490. PubMed ID: 37533096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.
    Ebrahimi-Mousavi S; Alavian SM; Sohrabpour AA; Dashti F; Djafarian K; Esmaillzadeh A
    BMC Gastroenterol; 2022 Mar; 22(1):102. PubMed ID: 35255811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
    Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of web-based interventions on non-alcoholic fatty liver disease (NAFLD) in obese children: A study protocol for a randomized controlled trial.
    Tian C; Xu J; Wang G; Yu L; Tang X
    Front Public Health; 2022; 10():930901. PubMed ID: 36339187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.
    Dashti F; Alavian SM; Sohrabpour AA; Mousavi SE; Keshavarz SA; Esmaillzadeh A
    BMJ Open; 2023 Apr; 13(4):e063988. PubMed ID: 37117000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial.
    Yurtdaş G; Akbulut G; Baran M; Yılmaz C
    Pediatr Obes; 2022 Apr; 17(4):e12872. PubMed ID: 34881510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
    Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation.
    Al-Awadi A; Grove J; Taylor M; Valdes A; Vijay A; Bawden S; Gowland P; Aithal G
    BMJ Open; 2021 Oct; 11(10):e045802. PubMed ID: 34620653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
    Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
    JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary sugar restriction on hepatic fat in youth with obesity.
    Distefano JK; Gerhard GS
    Minerva Pediatr (Torino); 2024 Jun; 76(3):439-448. PubMed ID: 37284808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.
    Mann JP; Tang GY; Nobili V; Armstrong MJ
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1457-1476.e7. PubMed ID: 29857146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.